Year |
Citation |
Score |
2023 |
Holborough-Kerkvliet MD, Mucignato G, Moons SJ, Psomiadou V, Konada RSR, Pedowitz NJ, Pratt MR, Kissel T, Koeleman CAM, Tjokrodirijo RTN, van Veelen PA, Huizinga T, van Schie KAJ, Wuhrer M, Kohler JJ, et al. A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners. Glycobiology. 33: 732-744. PMID 37498177 DOI: 10.1093/glycob/cwad055 |
0.518 |
|
2022 |
Yarravarapu N, Konada RSR, Darabedian N, Pedowitz NJ, Krishnamurthy SN, Pratt MR, Kohler JJ. Exo-Enzymatic Addition of Diazirine-Modified Sialic Acid to Cell Surfaces Enables Photocrosslinking of Glycoproteins. Bioconjugate Chemistry. PMID 35437982 DOI: 10.1021/acs.bioconjchem.2c00037 |
0.527 |
|
2022 |
Morales MM, Pedowitz NJ, Pratt MR. A 2D and 3D cell culture protocol to study O-GlcNAc in sphingosine-1-phosphate mediated fibroblast contraction. Star Protocols. 3: 101113. PMID 35118425 DOI: 10.1016/j.xpro.2021.101113 |
0.637 |
|
2021 |
Pedowitz NJ, Pratt MR. Design and Synthesis of Metabolic Chemical Reporters for the Visualization and Identification of Glycoproteins. Rsc Chemical Biology. 2: 306-321. PMID 34337414 DOI: 10.1039/d1cb00010a |
0.569 |
|
2021 |
Pedowitz NJ, Jackson EG, Overhulse JM, McKenna CE, Kohler JJ, Pratt MR. Anomeric Fatty Acid Functionalization Prevents Nonenzymatic -Glycosylation by Monosaccharide Metabolic Chemical Reporters. Acs Chemical Biology. PMID 34282887 DOI: 10.1021/acschembio.1c00470 |
0.653 |
|
2021 |
Morales MM, Pedowitz NJ, Pratt MR. O-GlcNAc modification of MYPT1 modulates lysophosphatidic acid (LPA)-induced cell contraction in fibroblasts. The Journal of Biological Chemistry. 100800. PMID 34019870 DOI: 10.1016/j.jbc.2021.100800 |
0.706 |
|
2021 |
Balana AT, Levine PM, Craven TW, Mukherjee S, Pedowitz NJ, Moon SP, Takahashi TT, Becker CFW, Baker D, Pratt MR. O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity. Nature Chemistry. PMID 33723378 DOI: 10.1038/s41557-021-00648-8 |
0.541 |
|
2020 |
Pedowitz NJ, Batt AR, Darabedian N, Pratt MR. MYPT1 O-GlcNAc modification regulates sphingosine-1-phosphate mediated contraction. Nature Chemical Biology. PMID 32929277 DOI: 10.1038/S41589-020-0640-8 |
0.69 |
|
2020 |
Pedowitz NJ, Zaro BW, Pratt MR. Metabolic Labeling for the Visualization and Identification of Potentially O-GlcNAc-Modified Proteins. Current Protocols in Chemical Biology. 12: e81. PMID 32289208 DOI: 10.1002/Cpch.81 |
0.728 |
|
2019 |
Walter LA, Lin YH, Halbrook CJ, Chuh KN, He L, Pedowitz NJ, Batt AR, Brennan CK, Stiles BL, Lyssiotis CA, Pratt MR. Inhibiting the hexosamine biosynthetic pathway lowers O-GlcNAcylation levels and sensitizes cancer to environmental stress. Biochemistry. PMID 31625393 DOI: 10.1021/Acs.Biochem.9B00560 |
0.679 |
|
Show low-probability matches. |